Mechanisms of neuronal death in Down’s syndrome
There is growing evidence that neuronal death in Down’s syndrome is due to apoptotic mechanisms. The phenomena, however, that trigger and regulate programmed cell death in the Down’s syndrome-related neurodegeneration are still much debated.
In vitro evidence has suggested that the main factor responsible for neuronal death in this condition is the accumulation of β-amyloid, due to the overexpression of its precursor protein. Another hypothesis argues for the importance of reactive oxygen species in neuronal death. However, the in vivo findings do not entirely support either theories.
We propose that neuronal apoptosis, as well as the formation of Alzheimer-type pathology, in Down’s syndrome is due to an aberrant re-entry of neurones into the cell division cycle. Due to the simultaneous over expression of conflicting cell cycle regulatory signals, the mitogenic amyloid precursor and the differentiation factor S100, the cell cycle is abandoned. Subsequently the cell cycle arrest may lead to either the formation of Alzheimer-related pathology or to apoptotic cell death.
KeywordsNeuronal Death Cell Division Cycle Paired Helical Filament Neurobiol Aging Paired Helical Filament
Unable to display preview. Download preview PDF.
- Au WW, Wilkinson GS, Tyring SK, Legator MS, el Zein R, Hallberg L, Heo MY (1996) Monitoring populations for DNA repair deficiency and for cancer susceptibility. Environ Health Perspect 3: 579–584Google Scholar
- Bar Peled O, Korkotian E, Segal M, Groner Y (1996) Constitutive overexpression of Cu/Zn superoxide dismutase exacerbates kainic acid-induced apoptosis of transgenic-Cu/Zn superoxide dismutase neurons. Proc Natl Acad Sci USA 93: 8530–8535Google Scholar
- Barkats M, Bertholet JY, Venault P, Ceballos Picot I, Nicole A, Phillips J, Moutier R, Roubertoux P, Sinet PM, Cohen Salmon C (1993) Hippocampal mossy fiber changes in mice transgenic for the human copper-zinc superoxide dismutase gene. Neurosci Lett 160: 24–28Google Scholar
- Mann DMA (1997) Neuropathological changes of Alzheimer’s disease in persons with Down’s syndrome. In: Esiri MM, Morris JH (eds) The neuropathology of dementia. Cambridge University Press, Cambridge, pp 122–136Google Scholar
- Mattiace LA, Kress Y, Davies P, Ksiezak Reding H, Yen SH, Dickson DW (1991) Ubiquitin-immunoreactive dystrophic neuntes in Down’s syndrome brains. J Neuropathol Exp Neurol 50: 547–559Google Scholar
- Nagy Zs, Esiri MM, Smith AD (1998) The cell division cycle and the pathophysiology of Alzheimer’s disease. Neuroscience 84: 731–739Google Scholar
- Vincent I, Ding XL, Zheng JH, Zhang SH (1998a) Mitotic kinases: initiators and mediators of neurodegeneration? Neurobiol Aging [Suppl] 4SGoogle Scholar
- Whitaker Azmitia PM, Wingate M, Borella A, Gerlai R, Roder J, Azmitia EC (1997) Transgenic mice overexpressing the neurotrophic factor S-100 beta show neuronal cytoskeletal and behavioral signs of altered aging processes: implications for Alzheimer’s disease and Down’s syndrome. Brain Res 776: 51–60Google Scholar